Kaitai Capital
凯泰资本
Kaitai Capital is a Chinese venture capital fund that appears in elsewhere's corpus primarily as a co-investor in early-stage tech deals. It led a $10 million follow-on round in AI drug-discovery startup Redesign Science in late 2021, with ZhenFund and existing shareholders participating , and was also among the investors in Xihu Xinchen's multi-million-dollar Pre-A round alongside Baidu Ventures and the Xihu Education Foundation . The fund's name in Chinese is 凯泰资本. Beyond these two deals, elsewhere's corpus does not cover its founding date, team, or overall strategy.
AI-generated — may contain errors, please verify.
Kaitai CapitalFund
凯泰资本
No graph yet
Mentioned in 3 articles
Coverage
Exclusive | The General-Purpose LLM Startup Wave: The First Battle Is About to End
Contestants, take your positions.
暗涌Waves·2022, the Door Opens to the Future | 5Y News Monthly
The big news from last month.
五源资本·5Y News | AI Drug Discovery Company Redesign Science Raises $15 Million
Advancing structure-based drug discovery.
五源资本·


